Table 3. Patient demographics, tumor characteristics, and treatment groups.
| Patient and tumor factors | Number of patients (% of total) (n = 90) | |
|---|---|---|
| Sex | Male | 72 (80%) |
| Female | 18 (20%) | |
| Primary subsite | Preauricular | 15 (17%) |
| Scalp | 15 (17%) | |
| Temple | 11 (12%) | |
| Forehead | 10 (11%) | |
| Cheek | 9 (10%) | |
| Ear | 8 (9%) | |
| Eyebrow | 8 (9%) | |
| Postauricular | 5 (6%) | |
| Nose | 4 (4%) | |
| Midface | 3 (3%) | |
| Lip | 1 (1%) | |
| Neck | 1 (1%) | |
| Histology | Squamous cell carcinoma | 68 (76%) |
| Basal cell carcinoma | 15 (17%) | |
| Other | 7 (8%) | |
| Prior treatments | Surgery | 74 (82%) |
| Radiation | 15 (17%) | |
| Immunosuppression | Yes | 18 (20%) |
| No | 72 (80%) | |
| Orbital invasion | Yes | 25 (28%) |
| No | 65 (72%) | |
| Treatment groups | Surgery alone | 15 (17%) |
| Radiation alone | 6 (7%) | |
| Surgery and radiation | 69 (77%) | |
| Complications | 30-d mortality | 2 (2%) |
| Stroke | 1 (1%) | |
| Myocardial infarction | 2 (2%) | |
| CSF leak | 5 (6%) | |
| Reconstructive flap failure | 2 (2%) | |
| Hematoma | 4 (4%) | |
Abbreviation: CSF, cerebrospinal fluid.